Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Karen Brigitta Goetz"'
Autor:
Robert A Johnson, Nele Berthels, Marc Baay, Adrian Wildfire, Volker Oeppling, Sarah M. Fortune, Isabelle Bekeredjian-Ding, Angela van Diepen, Christoph Conrad, Kawsar R. Talaat, Scott Stibitz, Peter G. Kremsner, Wolfram G. Metzger, Karen Brigitta Goetz, Wim Van Molle, Pieter Neels, Stephen J. Thomas, Yves Levy, Daniel F. Hoft, Beno Nyam Yakubu, Andrew Gorringe, Oleg Krut
Publikováno v:
Biologicals. 66:53-61
Controlled human infection models can be helpful to study pathogenesis and immune responses as a basis for the development of vaccines. In controlled human infection models, human challenge agents are used to infect healthy volunteers, therefore, eth
Publikováno v:
Nature Biotechnology
Several factors should be taken into account when it comes to the first exposure of humans to a novel vaccine.
Publikováno v:
Mucosal Delivery of Biopharmaceuticals ISBN: 9781461495239
Regulation of products for mucosal application has many points in common with products for other routes but also some that are unique. Identifying regulatory pitfalls is of tremendous importance early in development as this saves time, money, and ner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75ba2f5be694718ea24ee4ec2fb7ce61
https://doi.org/10.1007/978-1-4614-9524-6_25
https://doi.org/10.1007/978-1-4614-9524-6_25
Publikováno v:
Mucosal Delivery of Biopharmaceuticals; 2014, p539-589, 51p
Publikováno v:
Mucosal Delivery of Biopharmaceuticals; 2014, pi-xix, 19p
Autor:
José das Neves, Bruno Sarmento
Biopharmaceutical medicines, the newest class of therapeutics, are quite heterogeneous and include a range of molecules such as proteins, peptides, vaccines and nucleic acids, with use in virtually all therapeutic fields (e.g. cancer and infectious d